Prolonged Manual Ventilation Simulation

NCT ID: NCT06805838

Last Updated: 2025-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

102 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-25

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A pilot study on simulated lung scenarios using the standard manual resuscitator bag, flow limiting resuscitator bag, and an FDA approved flow rate limiting device paired with a standard manual resuscitator.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Manual Ventilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ambu + Normal lung compliance

Manual ventilation with Ambu bag and normal lung compliance.

Group Type NO_INTERVENTION

No interventions assigned to this group

Ambu + Low lung compliance

Manual ventilation with Ambu bag and low lung compliance.

Group Type NO_INTERVENTION

No interventions assigned to this group

Smart bag + Normal lung compliance

Manual ventilation with smart bag and normal lung compliance.

Group Type NO_INTERVENTION

No interventions assigned to this group

Smart bag + Low lung compliance

Manual ventilation with smart bag and low lung compliance.

Group Type NO_INTERVENTION

No interventions assigned to this group

Ambu + Sotair + Normal lung compliance

Manual ventilation with Ambu bag and Sotair device with normal lung compliance.

Group Type ACTIVE_COMPARATOR

Sotair

Intervention Type DEVICE

The device is a durable plastic connector with a silicone flap inside it requiring no special handling. There are no patients involved, only a simulated lung that also requires no special handling. Adult Sotair® device has FDA clearance as a Class II device through the 510(k) pathway (K212905) for the intended use of "Flow-limiting, safe, and optimal manual ventilation to minimize gastric insufflation."

Ambu + Sotair + Low compliance

Manual ventilation with Ambu bag and Sotair device with low lung compliance.

Group Type ACTIVE_COMPARATOR

Sotair

Intervention Type DEVICE

The device is a durable plastic connector with a silicone flap inside it requiring no special handling. There are no patients involved, only a simulated lung that also requires no special handling. Adult Sotair® device has FDA clearance as a Class II device through the 510(k) pathway (K212905) for the intended use of "Flow-limiting, safe, and optimal manual ventilation to minimize gastric insufflation."

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sotair

The device is a durable plastic connector with a silicone flap inside it requiring no special handling. There are no patients involved, only a simulated lung that also requires no special handling. Adult Sotair® device has FDA clearance as a Class II device through the 510(k) pathway (K212905) for the intended use of "Flow-limiting, safe, and optimal manual ventilation to minimize gastric insufflation."

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years old or older
* Have a current basic life support (BLS) certification
* Be available for the entire 10 hours to complete the protocol

Exclusion Criteria

* Any training in medical school or respiratory therapy school
* Not being available for the full 10 hours to complete the protocol
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Department of Defense

FED

Sponsor Role collaborator

SafeBVM

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark Brady, MD

Role: PRINCIPAL_INVESTIGATOR

Brown Physicians, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brown Physicians, Inc

Providence, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HT94252310316

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

DoD Ventilation Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Supplemental Oxygen Study
NCT02464917 COMPLETED NA